The U.S. Food and Drug Administration (FDA) announced that it will fast-track review of nine experimental drugs. The move is part of a Trump administration program aimed at prioritizing medicines that ...

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Akamis Bio, a clinical-stage oncology company using a proprietary Tumor-Specific Immuno-Gene Therapy (T-SIGn®) platform to deliver novel immunotherapeutic payloads ...

Rivers State Governor, Siminalayi Fubara, has said that the recent fire incident at a section of the state secretariat in Port Harcourt will accelerate his administration’s plans to rehabilitate the ...

EG110A targets type C sensory neurons to manage neurogenic detrusor overactivity-related incontinence, preserving other bladder controls. Fast track designation by the FDA allows EG110A to benefit ...

A new high-tech weapons detection system backed by artificial intelligence will soon be installed at the Washington County Courthouse, giving sheriff’s deputies more information while screening people ...

EL PASO, Texas (Border Report) — The Department of Homeland Security announced that it intends to waive dozens of environmental laws to expedite border wall construction in California. A Notice of ...

SAR446268 is a one-time adeno-associated viral gene therapy that delivers a vectorized RNA interference to silence DMPK expression. The Food and Drug Administration (FDA) has granted Fast Track ...